期刊文献+

IL-22、IL-27、VEGF、TF及TFPI对良恶性浆膜腔积液的鉴别价值

The Diagnostic Value of IL-22,IL-27,VEGF,TF and TFPI in Benign and Malignant Pleural Effusion
下载PDF
导出
摘要 目的评估浆膜腔积液中白介素22(interleukin-22,IL-22)、IL-2 7、血管内皮生长因子(vascular endothelial growth factor,VEGF)、组织因子(tissue factor,TF)和组织因子途径抑制物(tis sue factor pathway inhibitor,TFPI)水平在鉴别良恶性浆膜腔积液中的价值。方法应用酶联免疫吸附测定(E LISA)法检测41例病理学和影像学检测确诊为恶性浆膜腔积液患者、41例良性浆膜腔积液患者的浆膜腔积液中IL-22、IL-27、VEGF、TF和TFPI水平,并加以分析。结果恶性浆膜腔积液患者的浆膜腔积液中IL-22、IL-27、VEGF、TF和TFPI水平明显高于良性浆膜腔积液患者,差异均具有统计学意义(P<0.05)。ROC分析表明,恶性浆膜腔积液中IL-22、IL-27、VEGF、TF和TFPI的ROC曲线下面积分别为0.638、0.750、0.687、0.568和0.657。而联合这5个指标建立的预测诊断模型,ROC曲线下面积为0.793。结论浆膜腔积液中IL-22、IL-27、VEGF、TF和TFPI水平对鉴别良恶性浆膜腔积液有重要参考价值。 Objective To investigate the diagnostic value of IL-22,IL-27,VEGF,TF and TFPI inhibitor value in the benign and malignant pleural effusions. Method Selected ninety pleural patients were subdivided into two groups according to the Results of pathology and iconography diagnosis,ie the benign pleural effusions (benign) group with 43 cases and malignant pleural effusions (malignant) group with 47 cases. To test the diagnostic ability of several indicators used alone and in combination,the concentrations of IL-22,IL-27,VEFG,TF and TFPI were determined by ELISA Method,and the concentrations of these five biomarkers in pleural effusion were compared,then receiver operating curve (ROC) analysis was performed. Results A significant difference of IL-22,IL-27,VEGF,TF and TFPI levels were observed in patients with malignant and benign pleural effusion (P〈0.05). Receiver operating curve analysis indicated that several indicators used alone showed a less potent diagnostic ability of benign and malignant pleural effusion,the area under the ROC curve of less than 0.8; while these biomarkers used in combination showed an obvious improvement in sensitivity,specificity and accuracy. Conclusion The combination of several biomarkers can provide a reference for the differential diagnosis of benign and malignant pleural effusion. Because of the high accuracy,efficiency and simplicity,this Method is worthy promotion.
出处 《临床输血与检验》 CAS 2017年第1期63-66,共4页 Journal of Clinical Transfusion and Laboratory Medicine
基金 广东省深圳市龙岗区科技发展资金医疗卫生项目(No.YLWS20150513173417559)资助
  • 相关文献

参考文献4

二级参考文献70

  • 1Gregory Mark. Receiver-operating characteristic (ROC) plots: Fundamental Evaluation Tool in Clinical Medicine [ J ]. Clin Chem,1993, 30 (4): 561 - 567.
  • 2Hanley JA, McNeil BJ. The meaning and use of the area under a receiveroperating characteristic (ROC) curve [J]. Radiology, 1982,143 (4): 29.
  • 3Swets JA. Measuring the accuracy of dianostic system [J]. Science,1988, 240 (4622): 1285.
  • 4Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC)curve [J]. Radiology, 1982: 29-36.
  • 5王笑微,王鸿利.糖尿病微血管病变与血栓形成[J].中国实验诊断学,1997,1(1):22-25. 被引量:11
  • 6Akdis M, Palomares O, van de Veen W, van Splunt- er M, Akdis CA. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflamma- tion versus protection. J Allergy Clin Immunol 2012; 129: 1438-1449; 1438-1449; [PMID: 22657405 DOI: 10.1016/j.jaci.2012.05.003].
  • 7Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)I and T(H)2 cells. Nat Immunol 2009; 10:864-871 [PMID: 19578368 DOI: 10.1038/ni.1770].
  • 8Eyerich S, Eyerich K, Pennino D, Carbone T, Na- sorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl- Hoffmann C, Behrendt H, Durham SR, Schmidt- Weber CB, Cavani A. Th22 cells represent a distinct human T cell subset involved in epidermal immuni- ty and remodeling. J Clin Invest 2009; 119:3573-3585 [PMID: 19920355 DOI: 10.1172/JCI40202].
  • 9Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10:857-863 [PMID: 19578369].
  • 10Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived in- ducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000; 164:1814-1819 [PMID: 10657629].

共引文献231

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部